Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin’s Lymphoma
Condition(s):Lymphoma, Non-HodgkinLast Updated:January 11, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Non-HodgkinLast Updated:January 11, 2017Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:November 23, 2016Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:July 25, 2017Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:January 9, 2017Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:December 13, 2016Completed
Condition(s):Lymphoma, Non-Hodgkin’s, AdultLast Updated:November 22, 2023Not yet recruiting
Condition(s):Lymphoma, Non-HodgkinLast Updated:February 23, 2024Active, not recruiting
Condition(s):Lymphoma, Non-HodgkinLast Updated:June 26, 2017Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:December 12, 2016Completed
Condition(s):Lymphoma, Non-HodgkinLast Updated:May 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.